Stay updated on CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial

Sign up to get notified when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page revision/version label from v3.5.2 to v3.5.3, indicating a minor site build or UI release rather than a change to the underlying clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T06:39:18.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:49:07.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the Record History page.
    Difference
    0.1%
    Check dated 2026-03-19T06:35:23.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The record history now shows a new site revision (v3.4.3) added, replacing the previous revision (v3.4.2).
    Difference
    0.1%
    Check dated 2026-03-12T03:26:31.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    New Study Status and Recruitment Status entries were added, including a Terminated status on 2026-03-03, a 2026-02-27 update (version 16), and a <75% participation indicator. The previous 'Active, not recruiting' status entry was removed (as of 2025-11-21).
    Difference
    0.6%
    Check dated 2026-03-05T00:59:23.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    New revision entry Revision: v3.4.2 was added to the history and older notices including Revision: v3.4.1 and a site-wide government funding status notice were removed; these are administrative UI changes and do not affect the study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T12:18:10.000Z thumbnail image

Stay in the know with updates to CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.